NCT00369993已完成2 期
A Randomised, Open Label, Five-way Crossover Study to Assess the Systemic Exposure of Fluticasone Propionate and Salmeterol From SERETIDE/ADVAIR 250HFA MDI Alone and With AeroChamber-Max Spacer and VOLUMATIC Both in Their Washed and Unwashed States in Adult Subjects With Mild or Intermittent Asthma
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 20
- 试验地点
- 2
- 主要终点
- The pharmacokinetic profile of fluticasone propionate (in particular the area under the curve to time t and the maximum concentration)
研究概览
简要总结
Spacers are used by people with respiratory diseases who have problems using MDIs (metered dose inhalers). This study used fluticasone propionate/salmeterol to look at the pharmacokinetic profiles produced by different spacers in their washed and un-washed states.
详细描述
A randomised, open label, five-way crossover study to assess the systemic exposure of fluticasone propionate and salmeterol from SERETIDE™/ADVAIR™ 250 HFA MDI without spacer and with AeroChamber-Max spacer and VOLUMATIC™ both in their washed and unwashed states in adult subjects with mild or intermittent asthma.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
The pharmacokinetic profile of fluticasone propionate (in particular the area under the curve to time t and the maximum concentration)
次要结局
- The pharmacokinetic profile of salmeterol and the time to maximum concentration of fluticasone propionate
研究者
研究点 (2)
Loading locations...
相似试验
已完成
4 期
Evaluation of Onset of Effect in Patients With Severe Chronic Obstructive Pulmonary Disease (COPD) Treated With Symbicort® Compared to Seretide®Chronic Obstructive Pulmonary Disease (COPD)NCT00542880AstraZeneca442
招募中
不适用
Reducing Chronic Breathlessness in Adults by Following a Self-guided, Internet Based Supportive Intervention (SELF-BREATHE)DyspneaFibrotic Lung DiseaseChronic Lung DiseaseLung CancerChronic Obstructive Pulmonary DiseaseBronchiectasisInterstitial Lung DiseaseAsthmaNCT06326957King's College Hospital NHS Trust246
终止
不适用
Open Lung Ventilation in ARDS: The PHARLAP TrialAcute Respiratory Distress SyndromeNCT01667146Australian and New Zealand Intensive Care Research Centre115
已完成
2 期
Study to Assess Airway Inflammation Effects of FlutiForm® pMDI Low and High Dose in Adults With Mild to Moderate AsthmaAsthmaNCT00995800Mundipharma Research Limited46
招募中
3 期
A Phase III Trial of Anus-preservation in Low Rectal Adenocarcinoma Based on MMR/MSI StatusToripalimabRadiationNCT05669092Zhejiang Cancer Hospital174